JOINT CORP/THE (JYNT) Stock Fundamental Analysis
USA - NASDAQ:JYNT - US47973J1025 - Common Stock
8.22 USD
-0.04 (-0.48%)
8.22 USD
0 (0%)
Taking everything into account, JYNT scores 3 out of 10 in our fundamental rating. JYNT was compared to 100 industry peers in the Health Care Providers & Services industry. While JYNT seems to be doing ok healthwise, there are quite some concerns on its profitability. JYNT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
JYNT had negative earnings in the past year.
In the past year JYNT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: JYNT reported negative net income in multiple years.
JYNT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
JYNT's Return On Assets of -6.82% is on the low side compared to the rest of the industry. JYNT is outperformed by 72.00% of its industry peers.
With a Return On Equity value of -21.48%, JYNT is not doing good in the industry: 67.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.82% | ||
| ROE | -21.48% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 81.48%, JYNT belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
JYNT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for JYNT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JYNT has been increased compared to 1 year ago.
JYNT has more shares outstanding than it did 5 years ago.
JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.82 indicates that JYNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.82, JYNT is in the better half of the industry, outperforming 62.00% of the companies in the same industry.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.82 |
ROIC/WACCN/A
WACC9.14%
2.3 Liquidity
JYNT has a Current Ratio of 1.80. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.80, JYNT is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
A Quick Ratio of 1.80 indicates that JYNT should not have too much problems paying its short term obligations.
JYNT has a better Quick ratio (1.80) than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
JYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.03%, which is quite impressive.
Looking at the last year, JYNT shows a quite strong growth in Revenue. The Revenue has grown by 10.47% in the last year.
Measured over the past years, JYNT shows a small growth in Revenue. The Revenue has been growing by 1.36% on average per year.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)10.47%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
3.2 Future
JYNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.72% yearly.
JYNT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.57% yearly.
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for JYNT. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 22.39, the valuation of JYNT can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as JYNT.
JYNT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 22.39 |
4.2 Price Multiples
JYNT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.3 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as JYNT's earnings are expected to grow with 72.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y91.55%
EPS Next 3Y72.72%
5. Dividend
5.1 Amount
JYNT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
8.22
-0.04 (-0.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners77.63%
Inst Owner Change0.02%
Ins Owners8.65%
Ins Owner Change3.9%
Market Cap126.09M
Revenue(TTM)51.90M
Net Income(TTM)-4.99M
Analysts78.18
Price Target15.17 (84.55%)
Short Float %3.74%
Short Ratio5.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.93%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.53%
Revenue beat(4)1
Avg Revenue beat(4)-12.67%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)4.33%
Revenue beat(8)3
Avg Revenue beat(8)-6.08%
Revenue beat(12)4
Avg Revenue beat(12)-4.64%
Revenue beat(16)6
Avg Revenue beat(16)-3.78%
PT rev (1m)0%
PT rev (3m)-3.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)-107.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 22.39 | ||
| P/S | 1.16 | ||
| P/FCF | 37.3 | ||
| P/OCF | 26.58 | ||
| P/B | 5.43 | ||
| P/tB | 5.43 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.37
Fwd EY4.47%
FCF(TTM)0.22
FCFY2.68%
OCF(TTM)0.31
OCFY3.76%
SpS7.07
BVpS1.51
TBVpS1.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.82% | ||
| ROE | -21.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.48% | ||
| FCFM | 3.12% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 52.4% | ||
| Cap/Sales | 1.26% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 2.82 |
F-Score6
WACC9.14%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue 1Y (TTM)10.47%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
EBIT growth 1Y-162.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year313.77%
EBIT Next 3Y73.96%
EBIT Next 5YN/A
FCF growth 1Y-70.37%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-71.9%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to JYNT.
What is the valuation status for JYNT stock?
ChartMill assigns a valuation rating of 3 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for JYNT stock?
The Earnings per Share (EPS) of JOINT CORP/THE (JYNT) is expected to grow by 98.84% in the next year.